|
Volumn 23, Issue 2, 2015, Pages 196-201
|
Clinical effects of quadruple therapy based on antimicrobial susceptibility testing in treatment of helicobacter pylori associated upper digestive tract diseases
|
Author keywords
Helicobacter pylori infection; Individualized Treatment; Susceptibility; Upper digestive tract diseases
|
Indexed keywords
ANTIBIOTIC AGENT;
BISMUTH CITRATE;
CLARITHROMYCIN;
ESOMEPRAZOLE;
FURAZOLIDONE;
GENTAMICIN;
LEVOFLOXACIN;
METRONIDAZOLE;
PENICILLIN DERIVATIVE;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
ARTICLE;
COMPARATIVE STUDY;
CONTROLLED STUDY;
ENDOSCOPY;
ERADICATION THERAPY;
FOLLOW UP;
GASTROINTESTINAL DISEASE;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
INTENTION TO TREAT ANALYSIS;
MAJOR CLINICAL STUDY;
RANDOMIZED CONTROLLED TRIAL;
THERAPY EFFECT;
TREATMENT OUTCOME;
UREA BREATH TEST;
|
EID: 84922471256
PISSN: 10093079
EISSN: None
Source Type: Journal
DOI: 10.11569/wcjd.v23.i2.196 Document Type: Article |
Times cited : (7)
|
References (3)
|